EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion

Deguo Zhang iD, Da Man, Jiahua Lu, Yifan Jiang, Bo Ding, Rong Su, Rongliang Tong, Junru Chen, Beng Yang, Shusen Zheng, Diyu Chen, Jian Wu iD

Advanced Science · 2023-05 · 10 (15)

DOI: 10.1002/advs.202206669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.03.2023. Verfasst von Deguo Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangz…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Liver Neoplasms. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Zhejiang Province, National Natural Science Foundation of China, Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is one of the most common malignancies with poor prognosis, and novel treatment strategies are urgently needed. Mitochondria are key regulators of cellular homeostasis and potential targets for tumor therapy. Here, the role of mitochondrial translocator protein (TSPO) in the regulation of ferroptosis and antitumor immunity is investigated and the potential therapeutic implications for HCC are assessed. TSPO is highly expressed in HCC and associated with poor prognosis. Gain‐ and loss‐of‐function experiments present that TSPO promotes HCC cell growth, migration, and invasion in vitro and in vivo. In addition, TSPO inhibits ferroptosis in HCC cells via enhancing the Nrf2‐dependent antioxidant defense system. Mechanistically, TSPO directly interacts with P62 and interferes with autophagy, leading to the accumulation of P62. The P62 accumulation competes with KEAP1, preventing it from targeting Nrf2 for proteasomal degradation. Furthermore, TSPO promotes HCC immune escape by upregulating PD‐L1 expression through Nrf2‐mediated transcription. Notably, TSPO inhibitor PK11195 combines with anti‐PD‐1 antibody showing a synergistic anti‐tumor effect in a mouse model. Overall, the results demonstrated that mitochondrial TSPO promotes HCC progression by inhibiting ferroptosis and antitumor immunity. Targeting TSPO can be a promising new strategy for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularFerroptosisLiver NeoplasmsAnimalsMiceCarrier ProteinsImmune EvasionKelch-Like ECH-Associated Protein 1Mitochondrial ProteinsNF-E2-Related Factor 2Receptors, GABA

Stichwörter der Autor:innen

ferroptosishepatocellular carcinomaimmunotherapymitochondriatranslocator protein

Substanzen

Carrier ProteinsKelch-Like ECH-Associated Protein 1Mitochondrial ProteinsNF-E2-Related Factor 2Bzrp protein, mouseReceptors, GABA

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310003, China.
  • NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Zhejiang Province, 310003, China.
  • Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Ha…
  • Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, 310003, China.

ORCID-Profile: Deguo Zhang, Jian Wu

Förderung

  • Health Commission of Zhejiang Province
  • National Natural Science Foundation of China
  • Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China
  • Research Unit Project of Chinese Academy of Medical Sciences

Zitieren

APA

Zhang, D., Man, D., Lu, J., Jiang, Y., Ding, B., Su, R., Tong, R., Chen, J., Yang, B., Zheng, S., Chen, D., & Wu, J. (2023). Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science, 10(15). https://doi.org/10.1002/advs.202206669

Vancouver

Zhang D, Man D, Lu J, Jiang Y, Ding B, Su R, et al. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science. 2023;10(15). doi:10.1002/advs.202206669

BibTeX
@article{Zhang2023,
  author = {Zhang, Deguo and Man, Da and Lu, Jiahua and Jiang, Yifan and Ding, Bo and Su, Rong and Tong, Rongliang and Chen, Junru and Yang, Beng and Zheng, Shusen and Chen, Diyu and Wu, Jian},
  title = {Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {15},
  doi = {10.1002/advs.202206669}
}
Kostenlos starten →